Cáncer de vejiga

+ -Text Size

Otros recursos y referencias TEMAS

Referencias: guía detallada del cáncer de vejiga

Advanced Bladder (ABC) Meta-analysis Collaboration. Adjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis of individual patient data. European Urology. 2005;48:189-201.

Advanced Bladder (ABC) Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: Update of a systematic review and meta-analysis of individual patient data. European Urology. 2005;48:202-206.

American Cancer Society. Cancer Facts & Figures 2012. Atlanta, Ga: American Cancer Society; 2012.

American Cancer Society. Cancer Facts & Figures 2013. Atlanta, Ga: American Cancer Society; 2013.

American Joint Committee on Cancer. AJCC Cancer Staging Manual. Urinary Bladder. 7th ed. New York, NY: Springer; 2010: 497-502.

Carmack AJK, Soloway MS. The diagnosis and staging of bladder cancer from RBCs to TURs. Urology. 2006;67 (suppl 3A): 3-10.

Grossman HB, Messing E, Soloway M, et al. Detection of bladder cancer using a point-of-care proteomic assay. JAMA. 2005;293:810-816.

International Collaboration of Trialists. International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: Long-term results of the BA06 30894 trial. J Clin Oncol. 2011;29:2171-2177.

Kalsi J, Harland SJ, Feneley MR. Electromotive drug administration with mitomycin C for intravesical treatment of non-muscle invasive transitional cell carcinoma. Expert Opin Drug Deliv. 2008;5:137-145.

Kaufman DS, Shipley WU, Feldman AS. Bladder cancer. Lancet. 2009;374:239-249.

Lynch CF, Davila JA, Platz CE. Cancer of the urinary bladder. In: Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J, eds. SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and Tumor Characteristics. National Cancer Institute, SEER Program, NIH Pub. No. 07-6215, Bethesda, MD, 2007.

McDougal WS, Shipley WU, Kaufman DS, et al. Cancer of the bladder, ureter and renal pelvis. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2011.

National Cancer Institute. Physician Data Query (PDQ). Bladder Cancer Treatment. 2012. Accessed at www.cancer.gov/cancertopics/pdq/treatment/bladder/HealthProfessional on August 24, 2012.

National Comprehensive Cancer Network NCCN Clinical Practice Guidelines in Oncology. Bladder Cancer. V.2.2012. Accessed at www.nccn.org/professionals/physician_gls/pdf/bladder.pdf on August 24, 2012.

Smith DC, Montie J, Sandler H. Carcinoma of the bladder. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE, Kastan MB, McKenna WG, eds. Abeloff’s Clinical Oncology. 4th ed. Philadelphia, Pa. Elsevier: 2008: 1635-1652.

Weight CJ, Garcia JA, Hansel DE, et al. Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: A contemporary series. Cancer. 2009;15:792-799.

Fecha de última actualización: 01/22/2013
Fecha de último cambio o revisión: 01/22/2013